Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001472736 | SCV001676873 | likely benign | Hypertrophic cardiomyopathy | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002415851 | SCV002721639 | likely benign | Cardiovascular phenotype | 2018-05-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV001699231 | SCV001921292 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000199626 | SCV001953656 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000199626 | SCV001974347 | likely benign | not provided | no assertion criteria provided | clinical testing |